News

Live Science on MSN4d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Who can get updated COVID vaccines this fall? FDA tightening rules
The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...
FDA announces plans to restrict access for COVID vaccines
Shots would be available to those 65 and older and for those older than 6 months of age who have health conditions that make ...
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
Federal officials may limit recommendations for COVID vaccine
New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...
Covid vaccine rollout for healthy kids and adults likely delayed by new FDA rule
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups
Under the control of anti-vaccine advocate Robert F. Kennedy Jr., the Food and Drug Administration is unilaterally terminating universal access to seasonal COVID-19 vaccines; instead, only people who ...
The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...